Approval · Notice of Compliance 35432 · 2025
SOLUFY: Notice of Compliance 35432
Issued May 28, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35432
- Date
- May 28, 2025
- Company
- Orimed Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Administrative: Change in product name
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLUFY | 02554550 | Marketed |
Medicinal ingredients
- ARIPIPRAZOLE 1 MG per ML